Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
- RDEB is a lifelong debilitating, blistering skin disease associated with large and painful wounds that often remain open for years and cause significant clinical burden, including pain, itch, and risk of squamous cell carcinoma ...
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing
Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock Plus Therapeutics files a request to withdraw the related resale registration statement with the SEC ...
Calamos Breaks New Ground with Autocallable Income ETF ( CAIE ) , J.P. Morgan Serves as Swap Counterparty
CAIE democratizes $100+ billion annual autocallable yield note market through innovative new ETF. Autocallables have captured investor interest by delivering high stable monthly income potential tied to equity market performance, rather than duration or credit.1.
Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization
Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medications Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medications ...
Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch
NEW YORK and MELBOURNE, Australia, June 24, 2025 ( GLOBE NEWSWIRE ) -- Incannex Healthcare Inc. ( Nasdaq: IXHL ) ( "Incannex" or the "Company" ) , a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, announces the appointment of Douglas B.
BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer
PHILADELPHIA and VANCOUVER, British Columbia, June 24, 2025 ( GLOBE NEWSWIRE ) -- BriaCell Therapeutics Corp. ( Nasdaq: BCTX, BCTXW, BCTXZ ) ( TSX: BCT ) ( "BriaCell" or the "Company" ) , a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, is pleased ...
Sunrise Realty Trust Schedules Earnings Release and Conference Call for the Second Quarter Ending June 30, 2025
WEST PALM BEACH, Fla., June 24, 2025 ( GLOBE NEWSWIRE ) -- Sunrise Realty Trust, Inc. ( "SUNS" ) ( Nasdaq: SUNS ) , a lender on the Tannenbaum Capital Group ( "TCG" ) Real Estate platform, today announced that it will release its financial results for the second quarter ending June 30, 2025 on ...
Hong Kong stocks' rally to extend into second half, but risks remain: analysts
Hong Kong's stock market rally is expected to extend into the second half of the year, thanks to a surge of foreign investors seeking returns from equities, but analysts said US-China trade tensions could restrain upward momentum.
Up 55,810%, Is O'Reilly Automotive Stock Still a Buy?
If you had invested $10,000 into O'Reilly Automotive ( NASDAQ: ORLY ) in 1993, you would have $5.59 million today. You read that correctly -- shares have risen by a jaw-dropping 55,810% in 30 years.Typically, investors associate this type of massive growth with disruptive technology companies ...








